Butyrate or lifestyle change for liver disease in type 1 diabetes
Part of Hormones & metabolism, Immune system & allergy clinical trials.
This trial tests if taking butyrate (a gut-healthy substance) or making intensive lifestyle changes can improve fatty liver disease in people with type 1 diabetes. The goal is to see which approach helps the liver most.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You have type 1 diabetes.
- You have fatty liver disease, confirmed by a special ultrasound (FibroScan).
- You have not had heavy drinking in the past year (more than 5 drinks per day for men or 3 for women over 3 months).
- You do not have serious liver damage, other liver diseases, active cancer, or certain infections (like HIV or hepatitis).
- You are not pregnant or breastfeeding.
- You have not taken antibiotics or extra probiotics/prebiotics in the past month.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at fatty liver disease in adults with type 1 diabetes. It aims to understand how common it is and what factors might be linked, which could help improve care.
This study looks at how common liver fat build-up is in people with type 1 diabetes. It aims to understand what factors might increase the risk of liver problems.
This study tests if a special type of fat (butyrate) can help prevent diabetes in people who are overweight and have early signs of blood sugar problems. You would take a supplement for several weeks to see if it improves how your body handles sugar.
This trial tests whether taking probiotics plus making lifestyle changes can improve fatty liver and metabolic health. You may qualify if you have liver fat and at least one sign of metabolic problems like high blood sugar or high blood pressure.
This trial tests whether a special mix of probiotics can help improve liver health in people with fatty liver disease related to metabolism. It measures changes in liver enzymes, fat, and stiffness over time.
This trial tests whether taking a synbiotic (a mix of helpful bacteria and fiber) can improve insulin levels and reduce inflammation in people with Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD). It may help by changing the balance of bacteria in your gut.
Hear when a new Type 1 diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.